Jean-François Millau

Tatum Bio


Jean-François Millau holds a PhD in Biotech and is a Grenoble Business School graduate. Scientist-entrepreneur at heart, he designed the first biochip to measure DNA repair activities in human cells, which is now commercialized by LXRepair. Convinced that synthetic biology will revolutionize the pharmaceutical industry, he co-founded TATUM bioscience, a company developing a new class of immuno-oncology drugs based on programmable therapeutic bacteria.